Visiting CPHI Barcelona?
Schedule a Meet

Alectinib D5

Product Information

Product Alectinib D5
CAT No. CS-P-08187
CAS No. 1616374-15-2
Status price
Category Stable Isotopes
Mol. Wt. 487.65 mol/g
Mol. For. C30H29D5N4O2
Hazardous This is not a Hazardous Compound

Product Description

Alectinib D5 is a deuterated form of Alectinib, which is a highly selective small molecule inhibitor of the anaplastic lymphoma kinase (ALK) receptor tyrosine kinase. This drug is used to treat patients with non-small cell lung cancer (NSCLC) that is ALK-positive. It is also used in the treatment of ALK-positive metastatic NSCLC that is resistant or intolerant to crizotinib, another ALK inhibitor. Chemically, Alectinib D5 is a white to yellowish powder with a molecular weight of 503.71. It is stable under normal conditions and has a melting point of 120-130°C. This drug is soluble in DMSO and slightly soluble in water. The recommended dose of Alectinib D5 is 600 mg orally twice daily, with or without food. It should be taken at the same time every day to maintain a consistent level in the body. The duration of treatment depends on the patient's response and tolerability. Alectinib D5 works by inhibiting the activity of the ALK protein, which is involved in cell growth and proliferation in tumors. By blocking this protein, Alectinib D5 can slow down or stop the growth of cancer cells, leading to shrinkage of the tumor. Like any other medication, Alectinib D5 has some potential side effects, including constipation, fatigue, muscle pain, and vision problems. Patients should discuss any concerns with their healthcare provider before taking this drug.

Additional Information

Packing Product will be supplied in Vials, in certain conditions we also use 'Septa Vials'
Controlled No
Parent API Alectinib
Therapeutic Anti-Cancer / Oncology
Smileys O=C1C(C2=CC=C(C#N)C=C2N3)=C3C(C)(C)C4=CC(N5CCC(N6CCOCC6)CC5)=C(C([2H])([2H])C([2H])([2H])[2H])C=C14
Hazardous No

Need a Quote?

Your email address will not be published. Required fields are marked *

Safety & Handling Information

General Information Use proper personal protective equipment
Handling Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Engineering Control Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Clothing Wear appropriate protective clothing to minimize contact with skin.
Skin Wear appropriate protective gloves and clothing to prevent skin exposure.
Eyes Wear safety glasses and chemical goggles if splashing is possible.
Inhalation Remove from exposure and move to fresh air immediately.

What we promise?

  • 30-Days Money Back
  • Complete Documentation
  • Worldwide Delivery
  • Product Accuracy

Sample Label

logo Alectinib D5 www.clearsynth.com 
 CAT : CS-P-08187 BATCH : CSC-WWW0757

 MF: C30H29D5N4O2
 CAS: 1616374-15-2
 Date of Anaysis: 22-Aug-2023
 Retest Date: 22-Jun-2026
MW: 487.65

Store at refrigerator (2-8C)
Qty: 60 MG 
 Only for R & D and Analytical purpose, Not for Human Consumption.

Sample Packaging

Sample Packaging

Sample Vials

Sample Vials
Product List

Related Products